• Benign Prostatic Hyperplasia
  • Hormone Therapy
  • Genomic Testing
  • Next-Generation Imaging
  • UTUC
  • OAB and Incontinence
  • Genitourinary Cancers
  • Kidney Cancer
  • Men's Health
  • Pediatrics
  • Female Urology
  • Sexual Dysfunction
  • Kidney Stones
  • Urologic Surgery
  • Bladder Cancer
  • Benign Conditions
  • Prostate Cancer

Dr. Levin joins large Mid-Atlantic practice

Article

R.D. Levin, MD, has joined Chesapeake Urology Associates and will see patients in the practice's Pine Heights Medical Center and Maple Lawn/Columbia offices in Maryland.

R.D. Levin, MD, has joined Chesapeake Urology Associates and will see patients in the practice’s Pine Heights Medical Center and Maple Lawn/Columbia offices in Maryland.

Dr. Levin treats all aspects of adult urology. His special interests are in urologic oncology, kidney stone conditions, prostate health, BPH, low testosterone, female incontinence, and reconstructive urology.

Dr. Levin began practicing urology in 1996. Prior to joining Chesapeake Urology Associates, he was in private practice in Florida, where he also served as a urologic oncologist at Aventura Hospital Cancer Center and Mount Sinai Comprehensive Cancer Center, both in Aventura. In addition, he was a member of the surgical review committee at Mount Sinai Hospital Medical Center and the Miami Heart Institute.

Dr. Levin completed his urologic residency at George Washington University School of Medicine in Washington and a fellowship in immunotherapy for urologic cancer at the National Cancer Institute, Bethesda, MD.

Related Videos
Blurred interior of hospital |  Image Credit: © jakkapan - stock.adobe.com
Laura Bukavina, MD, MPH, answers a question during a Zoom video interview
Image of kidneys | Image Credit: © peterschreiber.media - stock.adobe.com
Neal Shore, MD, FACS, and Brian M. Shuch, MD, experts on kidney cancer
Neal Shore, MD, FACS, and Brian M. Shuch, MD, experts on kidney cancer
Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
Related Content
© 2024 MJH Life Sciences

All rights reserved.